Skip to main content
FinSpry Logo
FinSpry
ADPT logo
ADPT
(NASDAQ)
Adaptive Biotechnologies Corporation
$24.42-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Adaptive Biotechnologies Corporation (ADPT) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Adaptive Biotechnologies Corporation stock.

Analyst Consensus Rating

Investment consensus from 7 professional research analysts

Consensus Rating

Buy
Based on 7 unique analysts
(8 total ratings in last 90 days)
Medium Confidence5.0:1 Buy/Sell

Average Price Target

$22.50
↓ 7.86% Downside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest ADPT Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

NASDAQ:ADPT
Investing.com
BuyInitiates Coverage
-
UK
Investing.com
SellInitiates Coverage
-
Subbu Nambi
Guggenheim
BuyReiterates
$22.00 → $25.00
Zacks Equity Research
Zacks Equity Research
BuyInitiates Coverage
-
Jonathan Ponciano
The Motley Fool
BuyInitiates Coverage
-
Kallum Titchmarsh
Morgan Stanley
HoldMaintains
$18.00 → $20.00
Subbu Nambi
Guggenheim
BuyMaintains
$21.00 → $22.00
Andrew Brackmann
William Blair
BuyReiterates
-

Frequently Asked Questions

What is the analyst consensus rating for ADPT?

The analyst consensus rating for ADPT is "Buy" based on 7 analyst recommendations.

What is the average price target for ADPT?

The average 12-month price target for ADPT is $22.50, representing a downside of 7.9% from the current price of $24.42.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.